187 related articles for article (PubMed ID: 11114166)
21. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
[TBL] [Abstract][Full Text] [Related]
22. Upstream and downstream of mTOR.
Hay N; Sonenberg N
Genes Dev; 2004 Aug; 18(16):1926-45. PubMed ID: 15314020
[TBL] [Abstract][Full Text] [Related]
23. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
Inoki K; Li Y; Xu T; Guan KL
Genes Dev; 2003 Aug; 17(15):1829-34. PubMed ID: 12869586
[TBL] [Abstract][Full Text] [Related]
24. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
Inoki K; Li Y; Zhu T; Wu J; Guan KL
Nat Cell Biol; 2002 Sep; 4(9):648-57. PubMed ID: 12172553
[TBL] [Abstract][Full Text] [Related]
25. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
Manning BD; Tee AR; Logsdon MN; Blenis J; Cantley LC
Mol Cell; 2002 Jul; 10(1):151-62. PubMed ID: 12150915
[TBL] [Abstract][Full Text] [Related]
26. Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism.
Zhao T; Fan J; Abu-Zaid A; Burley SK; Zheng XFS
Cells; 2024 May; 13(9):. PubMed ID: 38727317
[TBL] [Abstract][Full Text] [Related]
27. p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer's disease.
Li JB; Hu XY; Chen MW; Xiong CH; Zhao N; Ge YH; Wang H; Gao XL; Xu NJ; Zhao LX; Yu ZH; Chen HZ; Qiu Y
Transl Neurodegener; 2023 Jan; 12(1):1. PubMed ID: 36624510
[TBL] [Abstract][Full Text] [Related]
28. P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.
Lin KH; Rutter JC; Xie A; Killarney ST; Vaganay C; Benaksas C; Ling F; Sodaro G; Meslin PA; Bassil CF; Fenouille N; Hoj J; Washart R; Ang HX; Cerda-Smith C; Chaintreuil P; Jacquel A; Auberger P; Forget A; Itzykson R; Lu M; Lin J; Pierobon M; Sheng Z; Li X; Chilkoti A; Owzar K; Rizzieri DA; Pardee TS; Benajiba L; Petricoin E; Puissant A; Wood KC
Nat Cancer; 2022 Jul; 3(7):837-851. PubMed ID: 35668193
[TBL] [Abstract][Full Text] [Related]
29. Rheb regulates nuclear mTORC1 activity independent of farnesylation.
Zhong Y; Zhou X; Guan KL; Zhang J
Cell Chem Biol; 2022 Jun; 29(6):1037-1045.e4. PubMed ID: 35294906
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the multifaceted nature of the nuclear function of mTOR.
Torres AS; Holz MK
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118907. PubMed ID: 33189783
[TBL] [Abstract][Full Text] [Related]
31. Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling.
Chen Z; Li S; Mo J; Hawley E; Wang Y; He Y; Brosseau JP; Shipman T; Clapp DW; Carroll TJ; Le LQ
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32960816
[TBL] [Abstract][Full Text] [Related]
32. Nuclear Functions of TOR: Impact on Transcription and the Epigenome.
Laribee RN; Weisman R
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32532005
[TBL] [Abstract][Full Text] [Related]
33. Quantum Blue Reduces the Severity of Woody Breast Myopathy via Modulation of Oxygen Homeostasis-Related Genes in Broiler Chickens.
Greene E; Flees J; Dadgar S; Mallmann B; Orlowski S; Dhamad A; Rochell S; Kidd M; Laurendon C; Whitfield H; Brearley C; Rajaram N; Walk C; Dridi S
Front Physiol; 2019; 10():1251. PubMed ID: 31632293
[TBL] [Abstract][Full Text] [Related]
34. XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.
Zhu ZC; Liu JW; Yang C; Zhao M; Xiong ZQ
Cell Death Dis; 2019 May; 10(6):395. PubMed ID: 31113936
[TBL] [Abstract][Full Text] [Related]
35. Direct imaging of the recruitment and phosphorylation of S6K1 in the mTORC1 pathway in living cells.
Ahmed AR; Owens RJ; Stubbs CD; Parker AW; Hitchman R; Yadav RB; Dumoux M; Hawes C; Botchway SW
Sci Rep; 2019 Mar; 9(1):3408. PubMed ID: 30833605
[TBL] [Abstract][Full Text] [Related]
36. A Unique Homeostatic Signaling Pathway Links Synaptic Inactivity to Postsynaptic mTORC1.
Henry FE; Wang X; Serrano D; Perez AS; Carruthers CJL; Stuenkel EL; Sutton MA
J Neurosci; 2018 Feb; 38(9):2207-2225. PubMed ID: 29311141
[TBL] [Abstract][Full Text] [Related]
37. Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70
Ma J; Kala S; Yung S; Chan TM; Cao Y; Jiang Y; Liu X; Giorgio S; Peng L; Wong AST
Mol Ther; 2018 Jan; 26(1):70-83. PubMed ID: 29241971
[TBL] [Abstract][Full Text] [Related]
38. An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer.
Wu L; Zhou B; Oshiro-Rapley N; Li M; Paulo JA; Webster CM; Mou F; Kacergis MC; Talkowski ME; Carr CE; Gygi SP; Zheng B; Soukas AA
Cell; 2016 Dec; 167(7):1705-1718.e13. PubMed ID: 27984722
[TBL] [Abstract][Full Text] [Related]
39. Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway.
Shao WY; Yang YL; Yan H; Huang Q; Liu KJ; Zhang S
Cancer Biol Ther; 2017 Jan; 18(1):26-35. PubMed ID: 27981892
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor-D modulates oxidant-antioxidant balance of human vascular endothelial cells.
Papiewska-Pająk I; Balcerczyk A; Stec-Martyna E; Koziołkiewicz W; Boncela J
J Cell Mol Med; 2017 Jun; 21(6):1139-1149. PubMed ID: 27957793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
